ACXP
Price
$2.19
Change
+$0.13 (+6.31%)
Updated
Feb 6 closing price
Capitalization
5.63M
Intraday BUY SELL Signals
QNCX
Price
$0.14
Change
-$0.01 (-6.67%)
Updated
Feb 6 closing price
Capitalization
7.75M
23 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACXP vs QNCX

Header iconACXP vs QNCX Comparison
Open Charts ACXP vs QNCXBanner chart's image
Acurx Pharmaceuticals
Price$2.19
Change+$0.13 (+6.31%)
Volume$44.55K
Capitalization5.63M
Quince Therapeutics
Price$0.14
Change-$0.01 (-6.67%)
Volume$4.95M
Capitalization7.75M
ACXP vs QNCX Comparison Chart in %
ACXP
Daily Signal:
Gain/Loss:
QNCX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ACXP vs. QNCX commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACXP is a Hold and QNCX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (ACXP: $2.19 vs. QNCX: $0.14)
Brand notoriety: ACXP and QNCX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACXP: 67% vs. QNCX: 173%
Market capitalization -- ACXP: $5.63M vs. QNCX: $7.75M
ACXP [@Biotechnology] is valued at $5.63M. QNCX’s [@Biotechnology] market capitalization is $7.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACXP’s FA Score shows that 1 FA rating(s) are green whileQNCX’s FA Score has 0 green FA rating(s).

  • ACXP’s FA Score: 1 green, 4 red.
  • QNCX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACXP and QNCX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACXP’s TA Score shows that 3 TA indicator(s) are bullish while QNCX’s TA Score has 4 bullish TA indicator(s).

  • ACXP’s TA Score: 3 bullish, 4 bearish.
  • QNCX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ACXP is a better buy in the short-term than QNCX.

Price Growth

ACXP (@Biotechnology) experienced а -7.40% price change this week, while QNCX (@Biotechnology) price change was -18.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

QNCX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QNCX($7.75M) has a higher market cap than ACXP($5.63M). ACXP YTD gains are higher at: -12.048 vs. QNCX (-95.848). ACXP has higher annual earnings (EBITDA): -9.25M vs. QNCX (-44.18M). QNCX has more cash in the bank: 26.3M vs. ACXP (5.91M). ACXP has less debt than QNCX: ACXP (66.5K) vs QNCX (18M). ACXP (0) and QNCX (0) have equivalent revenues.
ACXPQNCXACXP / QNCX
Capitalization5.63M7.75M73%
EBITDA-9.25M-44.18M21%
Gain YTD-12.048-95.84813%
P/E RatioN/AN/A-
Revenue00-
Total Cash5.91M26.3M22%
Total Debt66.5K18M0%
FUNDAMENTALS RATINGS
QNCX: Fundamental Ratings
QNCX
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
99
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACXPQNCX
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend about 1 month ago
76%
Bullish Trend 27 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ACXP
Daily Signal:
Gain/Loss:
QNCX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LCFY3.020.36
+13.53%
Locafy Limited
DIOD60.841.13
+1.89%
Diodes
NPB17.230.16
+0.94%
Northpointe Bancshares Inc
STHO7.930.04
+0.51%
Star Holdings
CNC38.46-1.46
-3.66%
Centene Corp

ACXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACXP has been loosely correlated with XBIO. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ACXP jumps, then XBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACXP
1D Price
Change %
ACXP100%
+6.31%
XBIO - ACXP
62%
Loosely correlated
N/A
VTGN - ACXP
60%
Loosely correlated
+11.52%
ARTV - ACXP
60%
Loosely correlated
+4.13%
QNCX - ACXP
57%
Loosely correlated
-4.79%
TPST - ACXP
56%
Loosely correlated
+7.62%
More

QNCX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNCX has been closely correlated with ARTV. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if QNCX jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
-4.79%
ARTV - QNCX
94%
Closely correlated
+4.13%
VTGN - QNCX
91%
Closely correlated
+11.52%
MREO - QNCX
85%
Closely correlated
+13.20%
CALC - QNCX
85%
Closely correlated
-1.77%
TPST - QNCX
84%
Closely correlated
+7.62%
More